Stents plus drugs vs. drugs alone: which is better for heart failure?
NCT ID NCT07349979
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares two approaches for people with heart failure and narrowed heart arteries: a stent procedure plus guideline-directed medications versus medications alone. About 1,150 participants will be followed for at least two years to see which group has fewer major heart problems like heart attacks, hospitalizations, or death. The goal is to find out if adding a stent improves outcomes beyond what medications can achieve.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- heart stent procedure (percutaneous coronary intervention) plus standard heart failure medications
- What this could lead to
- If it works, this could show that combining stents with medications is better than medications alone for preventing heart attacks, hospitalizations, and death in people with heart failure.
- What could go wrong
- This trial hasn't started yet, so results are years away. The procedure carries risks like bleeding or vessel damage, and the benefit over medications alone may be small or absent.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Nanjing First Hospital, Nanjing Medical University
Nanjing, Jiangsu, 210006, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Software-Guided heart procedures: a new standard for coronary care?
- Could continuing a common heart drug before surgery save lives?
- Heart patients may stay active longer with coach calls and group support
- Sitting less could be a lifeline for frail hearts – a new trial tests a simple program
- Can balloon timing make or break heart artery success?
- Can we predict which heart aneurysms will grow?